Quick Answer
Cordyceps Sunshine Biotech Holdings Co., Ltd. reported Total Revenue of $1.25 million for fiscal year 2024.
Cordyceps Sunshine Biotech Holdings Co., Ltd. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2024 | $1.25M | +42.0% |
| 2023 | $882.5K | +1555.7% |
| 2022 | $53.3K | -93.9% |
| 2021 | $879.3K | — |
- Cordyceps Sunshine Biotech Holdings Co., Ltd. showed an increase of +42.0% in Total Revenue compared to the prior fiscal year.
- Over the 2021–2024 period, Cordyceps Sunshine Biotech Holdings Co., Ltd.’s total revenue has grown by 42.6% (from $879.3 thousand to $1.25 million).
- The most recent figure is from Cordyceps Sunshine Biotech Holdings Co., Ltd.’s fiscal year 2024 report (Form 20-F), filed with the SEC on June 13, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: